ECSP982761A - Composiciones celecoxib - Google Patents

Composiciones celecoxib

Info

Publication number
ECSP982761A
ECSP982761A ECSP982761A ECSP982761A EC SP982761 A ECSP982761 A EC SP982761A EC SP982761 A ECSP982761 A EC SP982761A EC SP982761 A ECSP982761 A EC SP982761A
Authority
EC
Ecuador
Prior art keywords
celecoxib compositions
celecoxib
cyclooxygenase
disorders
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Margaret B Woodhull Vaughn
Danchen Gao
Anthony HLINAK
Ahmad M Mazhary
James E Truelove
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982761 priority Critical patent/ECSP982761A/es
Publication of ECSP982761A publication Critical patent/ECSP982761A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se relaciona con composiciones farmacéuticas orales útiles en el tratamiento de ciclooxigenasa-2-, condiciones mediana y/o desórdenes que comprende un agente activo de celecoxib en una cantidad desde aproximadamente 10 mg a aproximadamente 1000mg y uno o más materiales portadores.
ECSP982761 1998-11-30 1998-11-30 Composiciones celecoxib ECSP982761A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982761 ECSP982761A (es) 1998-11-30 1998-11-30 Composiciones celecoxib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982761 ECSP982761A (es) 1998-11-30 1998-11-30 Composiciones celecoxib

Publications (1)

Publication Number Publication Date
ECSP982761A true ECSP982761A (es) 1999-05-06

Family

ID=42043680

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982761 ECSP982761A (es) 1998-11-30 1998-11-30 Composiciones celecoxib

Country Status (1)

Country Link
EC (1) ECSP982761A (es)

Similar Documents

Publication Publication Date Title
BR9810495A (pt) Composição farmacêutica
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ATE246514T1 (de) Paclitaxel enthaltende arzneimittel
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
CR6210A (es) Composiciones de celecoxib
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
BRPI0519212A2 (pt) composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial
SG147485A1 (en) Pharmaceutical compositions for prevention of overdose or abuse
MY125651A (en) Eplerenone compositions
SE0003449D0 (sv) Anticancer compositions
WO2002051424A8 (en) Drugs against articular failure
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
UY27598A1 (es) Composiciones farmacéuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
UY26715A1 (es) Emulsiones con ésteres de naftalato
WO2005007137A3 (de) Ambroxolhaltige tabletten
MXPA04001398A (es) Metodo para el tratamiento y prevencion de dolor e inflamacion con glucosamina y un inhibidor selectivo de ciclooxigenasa-2 y composiciones para el mismo.
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
BR0010708A (pt) Glicosìdeos androgênicos e atividade androgênica dos mesmos
AU6469401A (en) Pharmaceutically active compounds and methods of use
FR2801218B1 (fr) Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
AR037131A1 (es) Formulaciones de jarabe de ribavirina
MA27102A1 (fr) Composition pharmaceutique orodispersible d'ivabradine
ES2192420T3 (es) Utilizacion de una composicion farmaceutica que comprende un agente anticanceroso y al menos un peptido.